The Retrofit: Lessons From Sotorasib's Dosing Conundrum
J Clin Oncol
.
2024 Oct 7:JCO2400310.
doi: 10.1200/JCO.24.00310.
Online ahead of print.
Authors
Harpreet Singh
1
,
Paz J Vellanki
2
,
Richard Pazdur
1
Affiliations
1
Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD.
2
Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
PMID:
39374478
DOI:
10.1200/JCO.24.00310
No abstract available